Our Mission

Supporting innovators to fight drug-resistant infections

INCATE brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe to accelerate your innovation. We do this by providing advice, community and funding. Our focus is on the development of new therapies, diagnostics and interventions that help reduce the prevalence and impact of Antimicrobial Resistance (AMR).

Our Vision

Bridge the gap!

How we help

What we do

Supporting your venture


Advice from partners, including Industry, to enable; early alignment with medical needs and market demand, the development of a quality translational path and a plan to build a company.


Access to a community of engaged individuals across industry, academia, entrepreneurs, policymakers, investors, public health and healthcare providers to share ideas and fight drug-resistant bacterial infections together.


Up to €250,000 in non-dilutive funding  will be provided to selected projects to help answer critical questions needed to develop business and translational plans to convince investors at the next funding stage.

How we help


INCATE combines the know-how and resources of Academic Members, Industry and Supporting Partners to support your innovation.

About us

INCATE Academic Members

INCATE Industry Partners

INCATE Supporting Partners


Contact us!

Dr. Helmut Kessmann

Contact me for Industry contacts and equity funding


Dr. Silke Alt

Contact me for advice on scientific questions and Non-Dilutive funding


Dr. Florian Kloss

Contact me to support your strategic and technical development


Douglas Haggstrom

Contact me to get involved in the community or start your application


Sina Gerbach

Contact me for access to technical support